September 4, 2013
Pharmaceutical industry leaders will meet at NEXUS ’13, TraceLink’s life science leadership conference on September 23-24th in Princeton New Jersey, to share insights and develop solutions for secure track and trace compliance. This third annual event by TraceLink Inc., the leader in global pharmaceutical track and trace and supply network performance solutions, will help pharmaceutical companies, CMOs/CPOs, 3PLs and other supply chain participants build their complete playbook for reducing risk, cost and time in complying with serialization, ePedigree, reporting and other emerging global traceability regulations.
NEXUS ’13 brings together a noted group of session leaders including Pfizer, Merck, ROC IT Solutions, Optel Vision, Bill Fletcher, Dirk Rodgers, Ken Traub, Gary Lerner, the Blue Fin Group and Accenture. For more information or to register for NEXUS ’13, September 23-24th at the Westin Princeton at Forrestal Village in Princeton NJ, visit www.tracelink.com/nexus-13.
Throughout 18 interactive sessions full of true field experience, NEXUS ’13 will examine all facets of global track and trace compliance strategy, planning, technical design, program management and supply network deployment. Attendees will gain deep insights and lessons learned on topics including:
Supply chain, IT, distribution/logistics, packaging, trade relations and other teams attending NEXUS ’13 will walk away with specific actionable information that helps minimize compliance risk, reduce time-to-compliance and improve flexibility in meeting evolving regulatory requirements.
For questions on NEXUS ’13 or to learn more about how TraceLink can help your business ensure global track and trace compliance and improve supply network performance through a single connection to the TraceLink Life Sciences Cloud, our award-winning Amazon AWS Cloud-based supply network platform, visit www.tracelink.com
TraceLink protects patients, enables health, grows profits and ensures compliance for companies across the global Life Sciences network through the TraceLink Life Sciences Cloud. The TraceLink Life Sciences Cloud is an Amazon AWS-based cloud application platform enabling complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. Winner of numerous industry awards including the Amazon AWS Global Start-Up Challenge Grand Prize and the Edison Award for Innovation in Health Management, the TraceLink Life Sciences Cloud is relied upon by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit www.tracelink.com.
TraceLink is funded by FirstMark Capital. FirstMark Capital is an early stage venture capital firm based in New York City. Our mission is to partner with exceptional entrepreneurs who are changing the world by solving meaningful problems. We have built a deeply engaged community among the extraordinary teams in our network to spread ideas and opportunities. We are privileged to work alongside the founders of remarkable businesses like Pinterest, Lumosity, Aereo, TapAd, Shopify, Riot Games, and dozens more. Visit us in New York City or online at firstmarkcap.com and @FirstMarkCap.